Profiel
Amy L.
Grogg, PharmD, is Senior Vice President of Strategy and Commercialization for AmerisourceBergen.
Dr. Grogg develops strategies to advance AmerisourceBergen's leadership in the pharmaceutical services industry and position AmerisourceBergen as the preferred commercialization partner for specialty pharmaceutical manufacturers.
Additionally, Dr. Grogg holds operational responsibility for Xcenda, part of AmerisourceBergen, which provides strategic consulting services for life sciences manufacturers commercializing products in the United States, Germany, and key global markets.
Actieve functies van Amy Grogg
| Bedrijven | Functie | Begin |
|---|---|---|
QualityMetric, Inc. LLC
QualityMetric, Inc. LLC Data Processing ServicesTechnology Services Engages in measuring patient health in clinical trials | Directeur/Bestuurslid | 01-09-2020 |
Solas Bioventures (mayfield) LLC
Solas Bioventures (mayfield) LLC Investment ManagersFinance Solas Bioventures invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, and digital health technologies. It provides financing for early stage capital requirements. | Consultant / Adviseur | 01-01-2022 |
GraphiteRx, Inc.
GraphiteRx, Inc. Internet Software/ServicesTechnology Services Operates as a healthcare marketplace platform for pharma needs | Consultant / Adviseur | 01-11-2020 |
Vesey Street Capital Partners LLC
Vesey Street Capital Partners LLC Investment ManagersFinance Vesey Street Capital Partners invests in lower middle market companies located in the US with an EBITDA of USD 10 - 20 million. The firm focuses on the healthcare sector. It provides financing for buyout, founder owned businesses and corporate carve-outs with an investment size of USD 75 - 120 million. The firm acquires majority and controlling stakes. | Consultant / Adviseur | 01-03-2022 |
Phenomics Health, Inc.
Phenomics Health, Inc. Packaged SoftwareTechnology Services Operates artificial intelligence and machine learning bioinformatics platform-based precision medicine company | Directeur/Bestuurslid | 01-01-2023 |
Eerdere bekende functies van Amy Grogg
| Bedrijven | Functie | Einde |
|---|---|---|
Real Chemistry, Inc.
Real Chemistry, Inc. Advertising/Marketing ServicesCommercial Services Provides advertising, communications and AI solutions for healthcare sector | Corporate Officer/Principal | 01-03-2022 |
| CENCORA, INC. | President | 01-01-2015 |
Xcenda LLC
Xcenda LLC Advertising/Marketing ServicesCommercial Services Provides branding services | President | 01-01-2013 |
Opleiding van Amy Grogg
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Cencora, Inc.
Cencora, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | Distribution Services |
Mercer University
Mercer University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xcenda LLC
Xcenda LLC Advertising/Marketing ServicesCommercial Services Provides branding services | Commercial Services |
Real Chemistry, Inc.
Real Chemistry, Inc. Advertising/Marketing ServicesCommercial Services Provides advertising, communications and AI solutions for healthcare sector | Commercial Services |
Solas Bioventures (mayfield) LLC
Solas Bioventures (mayfield) LLC Investment ManagersFinance Solas Bioventures invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, and digital health technologies. It provides financing for early stage capital requirements. | Finance |
Vesey Street Capital Partners LLC
Vesey Street Capital Partners LLC Investment ManagersFinance Vesey Street Capital Partners invests in lower middle market companies located in the US with an EBITDA of USD 10 - 20 million. The firm focuses on the healthcare sector. It provides financing for buyout, founder owned businesses and corporate carve-outs with an investment size of USD 75 - 120 million. The firm acquires majority and controlling stakes. | Finance |
Phenomics Health, Inc.
Phenomics Health, Inc. Packaged SoftwareTechnology Services Operates artificial intelligence and machine learning bioinformatics platform-based precision medicine company | Technology Services |
GraphiteRx, Inc.
GraphiteRx, Inc. Internet Software/ServicesTechnology Services Operates as a healthcare marketplace platform for pharma needs | Technology Services |
QualityMetric, Inc. LLC
QualityMetric, Inc. LLC Data Processing ServicesTechnology Services Engages in measuring patient health in clinical trials | Technology Services |
















